AEPCX
Price
$58.16
Change
+$0.03 (+0.05%)
Updated
Jun 5 closing price
Net Assets
133.44B
TIOSX
Price
$16.01
Change
-$0.03 (-0.19%)
Updated
Jun 5 closing price
Net Assets
2.35B
Interact to see
Advertisement

AEPCX vs TIOSX

Header iconAEPCX vs TIOSX Comparison
Open Charts AEPCX vs TIOSXBanner chart's image
American Funds EUPAC C
Price$58.16
Change+$0.03 (+0.05%)
VolumeN/A
Net Assets133.44B
Nuveen International Opps A
Price$16.01
Change-$0.03 (-0.19%)
VolumeN/A
Net Assets2.35B
AEPCX vs TIOSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPCX vs. TIOSX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and TIOSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. TIOSX (2.35B). TIOSX pays higher dividends than AEPCX: TIOSX (1.07) vs AEPCX (0.32). AEPCX was incepted earlier than TIOSX: AEPCX (24 years) vs TIOSX (12 years). AEPCX (1.59) is less costly to investors than TIOSX (0.95). AEPCX is a more actively managed with annual turnover of: 30.00 vs. TIOSX (21.00). AEPCX has a lower initial minimum investment than TIOSX: AEPCX (250) vs TIOSX (2500). TIOSX annual gain was more profitable for investors over the last year : 4.42 vs. AEPCX (2.04). TIOSX (14.83) and AEPCX (14.22) have equivalent 5 years return.
AEPCXTIOSXAEPCX / TIOSX
Total Expense Ratio1.590.95167%
Annual Report Gross Expense Ratio1.590.95167%
Fund Existence24 years12 years-
Gain YTD12.5029.488132%
Front LoadN/A6%-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets133B2.35B5,652%
Annual Yield % from dividends0.321.0730%
Returns for 1 year2.044.4246%
Returns for 3 years14.8215.7894%
Returns for 5 years14.2214.8396%
Returns for 10 years20.6749.1942%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNN30.301.03
+3.52%
Smith & Nephew plc
APLS19.100.59
+3.19%
Apellis Pharmaceuticals
CATO2.63-0.01
-0.38%
CATO Corp
STOK10.86-0.08
-0.73%
Stoke Therapeutics
GRI1.39-0.06
-4.14%
GRI Bio Inc.